Displaying One Session

View
Channel 2 ESMO Colloquium

ESMO Colloquium supported by GSK: Breakthroughs in molecular profiling and systemic therapies of endometrial and ovarian cancer (ID 91)

Date
21.11.2020
Time
17:35 - 19:05
Location
Channel 2
Chairs
  • Mansoor Raza Mirza (Copenhagen, Denmark)
  • Jonathan A. Ledermann (London, London, United Kingdom)
ESMO Colloquium supported by GSK: Breakthroughs in molecular profiling and systemic therapies of endometrial and ovarian cancer (ID 91) ESMO Colloquium

Molecular profiles of “actionable” aberrations in endometrial and ovarian cancer: The dawn of precision medicine (ID 1170)

Lecture Time
17:35 - 17:50
Speakers
  • Ignacio Romero (Valencia, Spain)
Session Name
ESMO Colloquium supported by GSK: Breakthroughs in molecular profiling and systemic therapies of endometrial and ovarian cancer (ID 91)
Location
Channel 2, Virtual Meeting, Virtual Meeting, Singapore
Date
21.11.2020
Time
17:35 - 19:05
ESMO Colloquium supported by GSK: Breakthroughs in molecular profiling and systemic therapies of endometrial and ovarian cancer (ID 91) ESMO Colloquium

The promise of immune checkpoint inhibitors in endometrial cancer (ID 1171)

Lecture Time
17:50 - 18:05
Speakers
  • Ana Oaknin (Barcelona, Spain)
Session Name
ESMO Colloquium supported by GSK: Breakthroughs in molecular profiling and systemic therapies of endometrial and ovarian cancer (ID 91)
Location
Channel 2, Virtual Meeting, Virtual Meeting, Singapore
Date
21.11.2020
Time
17:35 - 19:05
ESMO Colloquium supported by GSK: Breakthroughs in molecular profiling and systemic therapies of endometrial and ovarian cancer (ID 91) ESMO Colloquium

Treatment benefit from PARP inhibitors and resistance mechanisms in patients with advanced epithelial ovarian cancer: State of the art and new concepts (ID 1172)

Lecture Time
18:05 - 18:20
Speakers
  • Mansoor Raza Mirza (Copenhagen, Denmark)
Session Name
ESMO Colloquium supported by GSK: Breakthroughs in molecular profiling and systemic therapies of endometrial and ovarian cancer (ID 91)
Location
Channel 2, Virtual Meeting, Virtual Meeting, Singapore
Date
21.11.2020
Time
17:35 - 19:05
ESMO Colloquium supported by GSK: Breakthroughs in molecular profiling and systemic therapies of endometrial and ovarian cancer (ID 91) ESMO Colloquium

Emerging combinations of immune checkpoint inhibitors with targeted agents in ovarian and endometrial carcinomas (ID 1173)

Lecture Time
18:20 - 18:35
Speakers
  • Antonio Jose Gonzalez Martin (Madrid, Spain)
Session Name
ESMO Colloquium supported by GSK: Breakthroughs in molecular profiling and systemic therapies of endometrial and ovarian cancer (ID 91)
Location
Channel 2, Virtual Meeting, Virtual Meeting, Singapore
Date
21.11.2020
Time
17:35 - 19:05
ESMO Colloquium supported by GSK: Breakthroughs in molecular profiling and systemic therapies of endometrial and ovarian cancer (ID 91) ESMO Colloquium

Key messages and wrap up (ID 1174)

Lecture Time
18:35 - 18:45
Speakers
  • Jonathan A. Ledermann (London, London, United Kingdom)
Session Name
ESMO Colloquium supported by GSK: Breakthroughs in molecular profiling and systemic therapies of endometrial and ovarian cancer (ID 91)
Location
Channel 2, Virtual Meeting, Virtual Meeting, Singapore
Date
21.11.2020
Time
17:35 - 19:05
ESMO Colloquium supported by GSK: Breakthroughs in molecular profiling and systemic therapies of endometrial and ovarian cancer (ID 91) ESMO Colloquium

Live Q&A (ID 1175)

Lecture Time
18:45 - 19:05
Speakers
  • Mansoor Raza Mirza (Copenhagen, Denmark)
Session Name
ESMO Colloquium supported by GSK: Breakthroughs in molecular profiling and systemic therapies of endometrial and ovarian cancer (ID 91)
Location
Channel 2, Virtual Meeting, Virtual Meeting, Singapore
Date
21.11.2020
Time
17:35 - 19:05